Role of spironolactone in heart failure should be emphasised.
作者信息
Mapstone J, Houston B, Gogarty M
出版信息
BMJ. 2000 Sep 16;321(7262):706-7.
Abstract
摘要
相似文献
1
Role of spironolactone in heart failure should be emphasised.
BMJ. 2000 Sep 16;321(7262):706-7.
2
[Effect of aldosterone antagonism in heart failure: pharmacotherapeutic options].
Ned Tijdschr Geneeskd. 2001 Feb 3;145(5):204-8.
3
Spironolactone for heart failure: a worthy addition to therapy.
Adv Nurse Pract. 2001 Jan;9(1):34-6, 39.
4
[Chronic heart insufficiency should be treated also with spironolactone].
Ugeskr Laeger. 1999 Sep 13;161(37):5132.
5
Spironolactone in left-sided heart failure: how does it fit in?
Am Fam Physician. 2001 Oct 15;64(8):1393-8.
6
[New evidence for the usefulness of an old drug in the treatment of heart failure].
Rev Invest Clin. 2000 Jan-Feb;52(1):14-6.
7
New hope for heart failure.
Health News. 1999 Sep 10;5(11):1-2.
8
What's old is new again. Spironolactone and heart failure.
Can Fam Physician. 1999 Nov;45:2621-2.
9
Aldosterone antagonism in addition to angiotensin-converting enzyme inhibitors in heart failure.
Minerva Cardioangiol. 2003 Apr;51(2):155-64.
10
Effect of spironolactone on C-reactive protein levels in patients with heart disease.
Int J Cardiol. 2007 Apr 25;117(2):282-4. doi: 10.1016/j.ijcard.2006.05.069. Epub 2006 Aug 8.
引用本文的文献
本文引用的文献
1
Drug treatment in heart failure.
BMJ. 2000 Apr 29;320(7243):1188-92. doi: 10.1136/bmj.320.7243.1188.
2
The effect of spironolactone on morbidity and mortality in patients with severe heart failure. Randomized Aldactone Evaluation Study Investigators.
N Engl J Med. 1999 Sep 2;341(10):709-17. doi: 10.1056/NEJM199909023411001.
Zotero 插件